PubRank

Nadine Norton

Author PubWeight™ 71.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 2008 10.52
2 Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 2013 7.44
3 Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum Mol Genet 2007 5.28
4 Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet 2009 4.52
5 A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 2003 2.11
6 Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy. Circ Cardiovasc Genet 2010 1.98
7 Full genome screen for Alzheimer disease: stage II analysis. Am J Med Genet 2002 1.77
8 Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 2010 1.67
9 No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Science 2002 1.57
10 Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy. Clin Transl Sci 2010 1.52
11 Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Arch Gen Psychiatry 2005 1.48
12 Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Arch Gen Psychiatry 2010 1.46
13 Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. Proc Natl Acad Sci U S A 2006 1.25
14 Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 2005 1.22
15 Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder. Arch Gen Psychiatry 2006 1.19
16 Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. Br J Psychiatry 2007 1.19
17 Streamlined analysis of pooled genotype data in SNP-based association studies. Genet Epidemiol 2005 1.18
18 Support for RGS4 as a susceptibility gene for schizophrenia. Biol Psychiatry 2004 1.10
19 Association analysis of monoamine oxidase A and attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2003 1.08
20 Strong evidence that GNB1L is associated with schizophrenia. Hum Mol Genet 2007 1.07
21 SCN5A rare variants in familial dilated cardiomyopathy decrease peak sodium current depending on the common polymorphism H558R and common splice variant Q1077del. Clin Transl Sci 2010 1.07
22 Gene copy number variation in schizophrenia. Schizophr Res 2007 1.06
23 Genome-wide association study of multiplex schizophrenia pedigrees. Am J Psychiatry 2012 1.05
24 Convergent evidence for 2',3'-cyclic nucleotide 3'-phosphodiesterase as a possible susceptibility gene for schizophrenia. Arch Gen Psychiatry 2006 1.04
25 Variation in the protocadherin gamma A gene cluster. Genomics 2003 1.03
26 Polymorphisms in the MAOA, MAOB, and COMT genes and aggressive behavior in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2004 1.03
27 Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biol Psychiatry 2006 1.00
28 No association between schizophrenia and polymorphisms in COMT in two large samples. Am J Psychiatry 2005 1.00
29 Rare variant mutations identified in pediatric patients with dilated cardiomyopathy. Prog Pediatr Cardiol 2011 0.95
30 Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects. Arch Gen Psychiatry 2009 0.94
31 Functional characterization of TNNC1 rare variants identified in dilated cardiomyopathy. J Biol Chem 2011 0.92
32 Gene copy number variation in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2008 0.91
33 Whole genome association study in a homogenous population in Shandong peninsula of China reveals JARID2 as a susceptibility gene for schizophrenia. J Biomed Biotechnol 2009 0.89
34 Association between a promoter variant in the monoamine oxidase A gene and schizophrenia. Schizophr Res 2003 0.87
35 The human hyaluronan synthase genes: genomic structures, proximal promoters and polymorphic microsatellite markers. Int J Biochem Cell Biol 2003 0.84
36 Late onset sporadic dilated cardiomyopathy caused by a cardiac troponin T mutation. Clin Transl Sci 2010 0.81
37 Return of genetic results in the familial dilated cardiomyopathy research project. J Genet Couns 2012 0.81
38 A family based study implicates solute carrier family 1-member 3 (SLC1A3) gene in attention-deficit/hyperactivity disorder. Biol Psychiatry 2005 0.81
39 A regulatory monoamine oxidase a promoter polymorphism and personality traits. Neuropsychobiology 2002 0.78
40 How relevant is hormone receptor status in the context of outcome to HER2-positive breast cancer? Breast Cancer Res 2013 0.78
41 Further evidence for the association of MMP9 with nephropathy in type 2 diabetes and application of DNA pooling technology to candidate gene screening. J Nephrol 2008 0.77
42 Phenotype evaluation and genomewide linkage study of clinical variables in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2011 0.76
43 Analysis of copy number variation using quantitative interspecies competitive PCR. Nucleic Acids Res 2008 0.76
44 A functional polymorphism in the promoter of monoamine oxidase A gene and bipolar affective disorder. Int J Neuropsychopharmacol 1999 0.75
45 Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial. Pharmacogenet Genomics 2017 0.75